Helius Medical Technologies Stock Fundamentals
| HSDT Stock | USD 5.08 0.07 1.36% |
Helius Medical Technologies fundamentals help investors to digest information that contributes to Helius Medical's financial success or failures. It also enables traders to predict the movement of Helius Stock. The fundamental analysis module provides a way to measure Helius Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Helius Medical stock.
At this time, Helius Medical's Reconciled Depreciation is comparatively stable compared to the past year. Helius | Select Account or Indicator |
Helius Medical Technologies Company Operating Margin Analysis
Helius Medical's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Helius Medical Operating Margin | (16.76) % |
Most of Helius Medical's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Helius Medical Technologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Helius Pretax Profit Margin
Pretax Profit Margin |
|
Based on the recorded statements, Helius Medical Technologies has an Operating Margin of -16.7612%. This is 52.22% lower than that of the Health Care Equipment & Supplies sector and 57.36% lower than that of the Health Care industry. The operating margin for all United States stocks is notably higher than that of the company.
Helius Medical Techn Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Helius Medical's current stock value. Our valuation model uses many indicators to compare Helius Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Helius Medical competition to find correlations between indicators driving Helius Medical's intrinsic value. More Info.Helius Medical Technologies is rated below average in return on equity category among related companies. It is rated below average in return on asset category among related companies . At this time, Helius Medical's Return On Equity is comparatively stable compared to the past year.Comparative valuation analysis is a catch-all model that can be used if you cannot value Helius Medical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Helius Medical's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Helius Medical's earnings, one of the primary drivers of an investment's value.Helius Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Helius Medical's direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Helius Medical could also be used in its relative valuation, which is a method of valuing Helius Medical by comparing valuation metrics of similar companies.Helius Medical is currently under evaluation in operating margin category among related companies.
Helius Fundamentals
| Return On Equity | -1.69 | ||||
| Return On Asset | -0.61 | ||||
| Operating Margin | (16.76) % | ||||
| Current Valuation | (621.98 K) | ||||
| Shares Outstanding | 887.29 K | ||||
| Shares Owned By Insiders | 0.85 % | ||||
| Shares Owned By Institutions | 11.58 % | ||||
| Number Of Shares Shorted | 72.19 K | ||||
| Price To Earning | (13.85) X | ||||
| Price To Book | 2.22 X | ||||
| Price To Sales | 8.50 X | ||||
| Revenue | 644 K | ||||
| Gross Profit | 324 K | ||||
| EBITDA | (12.11 M) | ||||
| Net Income | (8.85 M) | ||||
| Cash And Equivalents | 3.27 M | ||||
| Cash Per Share | 0.12 X | ||||
| Total Debt | 57 K | ||||
| Debt To Equity | 0.03 % | ||||
| Current Ratio | 2.85 X | ||||
| Book Value Per Share | 3.29 X | ||||
| Cash Flow From Operations | (10.42 M) | ||||
| Short Ratio | 0.18 X | ||||
| Earnings Per Share | (14.56) X | ||||
| Target Price | 15.47 | ||||
| Number Of Employees | 22 | ||||
| Beta | 1.55 | ||||
| Market Capitalization | 4.5 M | ||||
| Total Asset | 7.69 M | ||||
| Retained Earnings | (159.96 M) | ||||
| Working Capital | 5.56 M | ||||
| Current Asset | 6.8 M | ||||
| Current Liabilities | 4.46 M | ||||
| Net Asset | 7.69 M |
About Helius Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Helius Medical Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Helius Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Helius Medical Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 43 K | 40.9 K | |
| Total Revenue | 644 K | 458.8 K | |
| Cost Of Revenue | 745 K | 782.2 K | |
| Stock Based Compensation To Revenue | 2.53 | 2.40 | |
| Sales General And Administrative To Revenue | 32.41 | 28.81 | |
| Research And Ddevelopement To Revenue | 4.57 | 4.34 | |
| Capex To Revenue | (0.05) | (0.05) | |
| Revenue Per Share | 1.06 | 1.01 | |
| Ebit Per Revenue | (19.05) | (20.00) |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Helius Medical Piotroski F Score and Helius Medical Altman Z Score analysis. Note that the Helius Medical Techn information on this page should be used as a complementary analysis to other Helius Medical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Helius Stock analysis
When running Helius Medical's price analysis, check to measure Helius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Helius Medical is operating at the current time. Most of Helius Medical's value examination focuses on studying past and present price action to predict the probability of Helius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Helius Medical's price. Additionally, you may evaluate how the addition of Helius Medical to your portfolios can decrease your overall portfolio volatility.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |
Is Helius Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Helius Medical. If investors know Helius will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Helius Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (14.56) | Revenue Per Share 1.059 | Quarterly Revenue Growth (0.53) | Return On Assets (0.61) | Return On Equity (1.69) |
The market value of Helius Medical Techn is measured differently than its book value, which is the value of Helius that is recorded on the company's balance sheet. Investors also form their own opinion of Helius Medical's value that differs from its market value or its book value, called intrinsic value, which is Helius Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Helius Medical's market value can be influenced by many factors that don't directly affect Helius Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Helius Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Helius Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Helius Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.